This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 May 29;9(7):368.

doi: 10.1038/nrclinonc.2012.95.

Clinical trials: New options for melanoma?

PMID: 22641362
DOI: 10.1038/nrclinonc.2012.95

Comment

Clinical trials: New options for melanoma?

Rebecca Kirk. Nat Rev Clin Oncol. 2012.

. 2012 May 29;9(7):368.

doi: 10.1038/nrclinonc.2012.95.

Author

PMID: 22641362
DOI: 10.1038/nrclinonc.2012.95

No abstract available

PubMed Disclaimer

Comment on

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
Falchook GS, Long GV, Kurzrock R, Kim KB, Arkenau TH, Brown MP, Hamid O, Infante JR, Millward M, Pavlick AC, O'Day SJ, Blackman SC, Curtis CM, Lebowitz P, Ma B, Ouellet D, Kefford RF. Falchook GS, et al. Lancet. 2012 May 19;379(9829):1893-901. doi: 10.1016/S0140-6736(12)60398-5. Lancet. 2012. PMID: 22608338 Free PMC article. Clinical Trial.

References

1. Lancet. 2012 May 19;379(9829):1893-901 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.